Keywords: Eli Lilly, FDA approval, Zyprexa Relprew, Schizophrenia

Eli Lilly gets bonus with FDA’s Zyprexa Relprew approval

Article | 04 January 2010

Print This

The US Food and Drug Administration last month approved drug major Eli Lilly’s Zyprexa Relprew (olanzapine), a new extended ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in